Plain-English translation of NCT06676410 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called Codivir® to see if it works better when added to standard HIV drugs for people who have never taken HIV treatment before. You would receive this medication as injections for 12 weeks, along with regular HIV pills that everyone in the study takes. The researchers want to know if this combination helps lower your viral load (the amount of HIV in your blood) more effectively than standard treatment alone.
Current HIV treatments work well for many people, but researchers are always looking for ways to help people control the virus even better and possibly achieve faster results. This study is testing whether this medication might give people newly starting treatment an extra boost to help their immune system recover more quickly.
You likely qualify if…
You likely don't qualify if…
You would participate for about 6 months total. First, some participants start with 2 weeks of daily injections before everyone else begins. Then everyone starts standard HIV pills that you take once daily. If you are in the medication group, you will also receive injections every other day for 12 weeks. Throughout the study, your blood will be checked regularly to measure your viral load and monitor how well the treatment is working. If the treatment is not working for you, the study team will stop your participation and help you access the best available care.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Brazil